AstraZeneca 2Q Rev. $6.45B; Est. $6.33B

July 31 (Bloomberg) –- Bloomberg’s Caroline Hyde reports earnings for AstraZeneca, Britain’s second-biggest drug maker, which raised its full-year forecast. She speaks to Mark Barton and Ryan Chilcote on Bloomberg Television’s “Countdown.” (Source: Bloomberg)
Aetna to Buy Humana for $37 Billion
09:49 - Bloomberg's Francine Lacqua and Manus Cranny report on today's "Top Headlines." They speak on Bloomberg Television's "The Pulse." (Source: Bloomberg)
  • No Single Personality Can Unite Greece Now: Michaletos
  • Global Stock Market Still in Pretty Good Shape: Gilbert
  • Greek 'No' Vote Would Make Euro Exit Likely: Nakisa